LEERINK CENTER FOR PHARMACOECONOMICS
Live / Allowed — Notice of allowance issued (as of 25 Nov 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Nov 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98876472
- Mark type
- Design + words
- Filed
- 27 Nov 2024
- Published for opposition
- 30 Sept 2025
- Attorney of record
- Cynthia J. Walden
Goods and services
- Class 009 — Scientific and electric apparatus: Downloadable reports, electronic newsletters and printable educational materials in the field of financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Downloadable computer software for organizing and sharing commentary, resources, and evaluations related to business information, financial information, and consulting for the same; Downloadable computer software and downloadable mobile applications for use in investment banking management, accessing and conducting banking and financial business, and obtaining information, research, analysis, and advice in the fields of investments, banking, and financial services
- Class 035 — Advertising and business services: Business consulting; Business advisory; Acquisition and merger consultation; Providing trade information; Compiling financial, securities, stock exchange, trade and quote, index value and other financial market information for business purposes; Business intermediary services relating to the matching of potential investors with corporations and entrepreneurs needing funding; Business consultation services, namely, business evaluation regarding firms in the biotechnology, pharmaceutical, and health fields for the assessment of the business value of medical and pharmaceutical innovation and technology
- Class 036 — Insurance and financial services: Financial services, namely consulting and advising related to financial matters in the biotechnology, pharmaceutical, and health fields for the assessment of the financial value of medical and pharmaceutical innovation and technology; Providing information related to financial matters in the biotechnology, pharmaceutical, and health fields for the assessment of the financial value of medical and pharmaceutical innovation and technology; Financial consulting; Investment advisory and consulting services; Financial services, namely, investment advice, investment management, investment consultation; Information, advisory, consultancy and financial research services relating to finance and investments
- Class 041 — Education and entertainment services: Providing a website featuring online non-downloadable content in the nature of instructional videos, related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videos, webinars and podcasts related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videos, webinars and podcasts in the field of finance; Arranging and conducting conferences and events in the field of finance
Owner
- Leerink Intermediate Holdings LLC, Boston, MA, US
- Leerink Intermediate Holdings LLC, Boston, MA, US
Prior registrations
Prosecution history
- 25 Nov 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Sept 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Sept 2025 — PUBLISHED FOR OPPOSITION
- 24 Sept 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Sept 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 28 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 May 2025 — NON-FINAL ACTION E-MAILED
- 28 May 2025 — NON-FINAL ACTION WRITTEN
- 20 May 2025 — ASSIGNED TO EXAMINER
- 15 May 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 15 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Nov 2024 — NEW APPLICATION ENTERED